PhenacetamideCAS# 103-81-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 103-81-1 | SDF | Download SDF |
PubChem ID | 7680 | Appearance | Powder |
Formula | C8H9NO | M.Wt | 135.16 |
Type of Compound | Impurities | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-phenylacetamide | ||
SMILES | C1=CC=C(C=C1)CC(=O)N | ||
Standard InChIKey | LSBDFXRDZJMBSC-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H9NO/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,9,10) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Phenacetamide Dilution Calculator
Phenacetamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 7.3986 mL | 36.9932 mL | 73.9864 mL | 147.9728 mL | 184.966 mL |
5 mM | 1.4797 mL | 7.3986 mL | 14.7973 mL | 29.5946 mL | 36.9932 mL |
10 mM | 0.7399 mL | 3.6993 mL | 7.3986 mL | 14.7973 mL | 18.4966 mL |
50 mM | 0.148 mL | 0.7399 mL | 1.4797 mL | 2.9595 mL | 3.6993 mL |
100 mM | 0.074 mL | 0.3699 mL | 0.7399 mL | 1.4797 mL | 1.8497 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-(1-Ethoxy-2-hydroxyethyl)benzene-1,2-diol
Catalog No.:BCX0223
CAS No.:1190632-33-7
- 3β,5α-Dihydroxystigmastan-6-one
Catalog No.:BCX0222
CAS No.:55051-78-0
- Fornicin A
Catalog No.:BCX0221
CAS No.:908588-41-0
- Cyclo(L-Pro-L-Ile)
Catalog No.:BCX0220
CAS No.:57089-60-8
- Cyclo(L-Pro-L-Val)
Catalog No.:BCX0219
CAS No.:2854-40-2
- Demethylmangostanin
Catalog No.:BCX0218
CAS No.:2289591-37-1
- Cyclo(L-Leu-L-Pro)
Catalog No.:BCX0217
CAS No.:2873-36-1
- 25,26,27-Trinor-3α-hydroxycycloartan-24-oic acid
Catalog No.:BCX0216
CAS No.:1300747-31-2
- 3'-Hydroxyliquiritin
Catalog No.:BCX0215
CAS No.:1442113-42-9
- Atalafoline
Catalog No.:BCX0214
CAS No.:59-49-4
- (2R,3S)-Pterosin C
Catalog No.:BCX0213
CAS No.:68399-17-7
- Gnetuhainin O
Catalog No.:BCX0212
CAS No.:337464-95-6
- 1,6,8-Trihydroxy-2,7-dimethoxy-3-methylanthraquinone
Catalog No.:BCX0225
CAS No.:2366153-27-5
- 1,3,5,7-Tetrahydroxy-8-prenylxanthone
Catalog No.:BCX0226
CAS No.:444004-76-6
- 22-Epiinotodiol
Catalog No.:BCX0227
CAS No.:64907-49-9
- Brasilixanthone B
Catalog No.:BCX0228
CAS No.:84002-57-3
- Makisterone A
Catalog No.:BCX0229
CAS No.:20137-14-8
- Apigenin 6-C-(2-O-feruloyl)glucoside 8-C-glucoside
Catalog No.:BCX0230
CAS No.:1287786-63-3
- Fibleucin
Catalog No.:BCX0231
CAS No.:24278-14-6
- N-Acetylnornuciferine
Catalog No.:BCX0232
CAS No.:1942-03-6
- Tinospin E
Catalog No.:BCX0233
CAS No.:1582321-96-7
- Turmeronol B
Catalog No.:BCX0234
CAS No.:131651-38-2
- Aristolodione
Catalog No.:BCX0235
CAS No.:109771-09-7
- Ciwujianoside C2
Catalog No.:BCX0236
CAS No.:114892-56-7
Preparation of dopaminergic N-alkyl-benzyltetrahydroisoquinolines using a 'one-pot' procedure in acid medium.[Pubmed:10882001]
Bioorg Med Chem. 2000 May;8(5):889-95.
The preparation of N-methyl-BTHIQ (4) from N-phenylethyl-Phenacetamide (1) by cyclization, reduction and N-alkylation in acid medium has been achieved in good yield in a 'one-pot' procedure. Acylation of imine (2) intermediate afforded the Z and E stereoselectivity in the enamide formation. 6-Hydroxy-BTHIQ (7) shows selectivity for D2 dopamine receptors, while its N-methylated homologue (8) displays higher affinities for both D1 and D2 receptor types, with an unexpected increase in D1 dopamine receptor affinity.